Procurement of Respiratory System Medications under CPA 2024/899

This tender relates to the procurement of medications for the respiratory system. The acquisition is being made under the Cooperative Purchasing Agreement (CPA) referenced as 2024/899. Respiratory medications are used to treat a variety of conditions affecting the lungs and airways, such as asthma, chronic obstructive pulmonary disease (COPD), pneumonia, and respiratory infections. The tender seeks to secure a supply of these essential drugs, likely for public health institutions or a consortium of healthcare providers participating in the CPA. The specific types of medications, dosages, formulations (e.g., inhalers, nebulizer solutions, oral tablets), quantities, and quality standards will be detailed in the tender documentation. The objective is to ensure the availability of effective treatments for patients with respiratory ailments through a coordinated and potentially cost-efficient purchasing process facilitated by the CPA. Suppliers will be evaluated based on their ability to meet the specified requirements and provide reliable delivery.

This is a supplies contract in the rural development, health and medical services and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 498.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the rural development sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.